Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic,…
Baxter Healthcare Corporation · CGMP Deviations
- Status
- Ongoing
- City
- Deerfield
- State
- IL
- Country
- United States
- Classification
- Class II
- Product type
- Drugs
- Event ID
- 99500
- Recalling firm
- Baxter Healthcare Corporation
- Address 1
- 1 Baxter Pkwy
- Address 2
- N/A
- Postal code
- 60015-4625
- Voluntary mandated
- Voluntary: Firm initiated
- Initial firm notification
- Letter
- Distribution pattern
- US Nationwide; Puerto Rico; and Chile.
- Recall number
- D-0815-2026
- Product quantity
- N/A
- Reason for recall
- CGMP Deviations
- Recall initiation date
- 20260806
- Center classification date
- 20260828
- Report date
- 20260909
- Code info
- Lot # NC185424, Exp Date: 2/12/2027; Lot # NC185479, Exp Date: 2/13/2027; Lot # NC193948, Exp Date: 10/23/2027.
- Product description
Clindamycin Injection USP in 5% Dextrose, 900 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-3814-50.
- Harmonized identifiers (openFDA)
- Application number
- ANDA208084
- Brand name
- CLINDAMYCIN PHOSPHATE
- Generic name
- CLINDAMYCIN PHOSPHATE
- Manufacturer name
- Baxter Healthcare Company
- Product NDC
- 0338-3410, 0338-3612, 0338-3814
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- CLINDAMYCIN PHOSPHATE
- RxCUI
- 309335, 309336, 309339
- SPL ID
- c8906ab2-37d2-4fde-9784-0442bf7b9565
- SPL set ID
- 78832ac6-04c5-45e0-ae4d-f56d7920dda9
- Package NDC
- 0338-3410-50, 0338-3410-24, 0338-3612-50, 0338-3612-24, 0338-3814-50, 0338-3814-24
- Is original packager
- true
- UNII
- EH6D7113I8
